Abstract
Nine comparative treatment plans are shown of proton beam therapy and photons for the treatment of multiple malignancies. Data is presented across multiple tumor sites including craniospinal, brain, prostate, spine, liver, and mediastinum showing the ability of proton beam therapy to reduce dose to normal organs at risk compared with photons in the properly selected patients. In the future, the list of clinical indications for proton beam therapy should continue to expand as there is growing recognition of the ability of proton beam therapy to adequately cover the intended target volume while sparing nearby normal tissues. Such sparing of nearby normal tissues from irradiation should reduce side effects of treatment and reduce the risk of developing secondary malignancies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Suit H. The Gray Lecture 2001: coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys. 2002;53(4):798–809.
Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation. Int J Radiat Oncol Biol Phys. 1997;38(4):805–11.
Brodin NP, Rosenschöld PM, Aznar MC, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol. 2011;50(6):806–16.
Rosenschöld PM, Engelholm S, Ohlhues L, Law I, Vogelius I, Engelholm SA. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol. 2011;50(6):777–83.
Boehling NS, Grosshans DR, Bluett JB, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012;82(2):643–52.
Yajnik S, Siddiqui M, Gao M, et al. Comparison of pelvic bone marrow dose from proton therapy and tomotherapy: a dosimetric study. Presented at the Particle Therapy Cooperative Group Annual Meeting in Seoul, South Korea; 2012.
Yajnik S, Siddiqui M, Gao M, et al. Proton beam therapy reduces dose to pelvic bone marrow compared with IMRT: a dosimetric study. Accepted for Poster Presentation at American Society for Radiation Oncology Annual Meeting; 2012.
Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol. 2011;50(6):823–8.
Amsbaugh MJ, Grosshans DR, McAleer MF, et al. Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys. 2012;83(5):1419–24.
Hoppe BS, Flampouri S, Su Z, et al. Mendenhall NPConsolidative involved-node proton therapy for stage IA-IIIA mediastinal Hodgkin’s Lymphoma: preliminary dosimetric outcomes from a phase II study. Int J Radiat Oncol Biol Phys. 2012;83(1):260–7.
Li J, Dabaja B, Reed V, et al. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys. 2011;81(1):167–74.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yajnik, S. (2013). Comparative Treatment Plans. In: Proton Beam Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5298-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5298-0_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5297-3
Online ISBN: 978-1-4614-5298-0
eBook Packages: MedicineMedicine (R0)